Autres langues Beijing Hotgen Biotech Co., Ltd.

Actions

688068

CNE100003P82

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 28/06/2024			Varia. 5j.	Varia. 1 janv.
25,83 ^CNY	+0,43 %		-4,72 %	-37,08 %

29/04	Beijing Hotgen Biotech Co. présente ses résultats pour le premier trimestre clos le 31 mars 2024	CI
28/02	Beijing Hotgen Biotech Co. publie ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Tranche Update on Beijing Hotgen Biotech Co., Ltd.'s Equity Buyback Plan announced on February 8, 2024.	08/05
Beijing Hotgen Biotech Co., Ltd.'s Equity Buyback announced on February 8, 2024, has closed with 2,893,010 shares, representing 3.24% for CNY 92.02 million.	07/05
Beijing Hotgen Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Beijing Hotgen Biotech to Buy Kaijing Gene Technology for 11 Million Yuan	16/04
Tranche Update on Beijing Hotgen Biotech Co., Ltd.'s Equity Buyback Plan announced on February 8, 2024.	03/04
Beijing Hotgen Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Beijing Hotgen Biotech Co., Ltd. announces an Equity Buyback for CNY 150 million worth of its shares.	08/02
Beijing Hotgen Biotech Co., Ltd. authorizes a Buyback Plan.	07/02
Beijing Hotgen Biotech Co., Ltd.(XSSC:688068) dropped from S&P Global BMI Index	18/12
Beijing Hotgen Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Beijing Hotgen Biotech Co., Ltd.(XSSC:688068) added to S&P Global BMI Index	18/09/23
Hangzhou Oriomics Biotechnology Co., Ltd. announced that it has received CNY 100 million in funding from Shenzhen Dachen Caizhi Venture Capital Management Co., Ltd., Tao Capital, Beijing Hotgen Biotech Co., Ltd. and other investors	11/09/23
Beijing Hotgen Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
Tranche Update on Beijing Hotgen Biotech Co., Ltd.'s Equity Buyback Plan announced on September 6, 2022.	16/06/23
Beijing Hotgen Biotech Co., Ltd.'s Equity Buyback announced on September 6, 2022 has closed with 2,861,477 shares, representing 3.12% for CNY 166.45 million.	13/06/23
Beijing Hotgen Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23
Tranche Update on Beijing Hotgen Biotech Co., Ltd.'s Equity Buyback Plan announced on September 6, 2022.	07/04/23
Beijing Hotgen Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
Tranche Update on Beijing Hotgen Biotech Co., Ltd.'s Equity Buyback Plan announced on September 6, 2022.	05/01/23
Beijing Hotgen Biotech Unit Secures Registration Certificate For Two Devices	22/12/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Beijing Hotgen Biotech Co., Ltd.

Actions

688068

CNE100003P82

Autres langues

Filtres